Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.78 |
| ▸ | MAPT | P10636 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | MPO | P05164 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | BLM | P54132 | 1/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.78 |
| ▸ | HTR2A | P28223 | 2/20 | 0.62 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.62 |
| ▸ | HTR1A | P08908 | 1/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.62 |
| ▸ | HTR1D | P28221 | 1/20 | 0.62 |
| ▸ | HTR1B | P28222 | 1/20 | 0.62 |
| ▸ | HTR2C | P28335 | 1/20 | 0.62 |
| ▸ | HTR1E | P28566 | 1/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2726806 | 1.00 | KDM4E (0.78) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL29865910 | 1.00 | KDM4E (0.78) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL8403649 | 1.00 | KDM4E (0.78) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL358778 | 1.00 | KDM4E (0.78) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL8403647 | 1.00 | KDM4E (0.78) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL29382126 | 1.00 | KDM4E (0.78) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL29400974 | 1.00 | KDM4E (0.78) | KDM4EMAPTMEN1LMNAMPO | |
| Hydrochloric Acid SCHEMBL3784313 | 0.98 | KDM4E (0.76) | KDM4EMAPTMEN1LMNAMPO | |
| Hydrochloric Acid SCHEMBL901447 | 0.98 | KDM4E (0.76) | KDM4EMAPTMEN1LMNAMPO | |
| Acetic Acid SCHEMBL25253474 | 0.94 | KDM4E (0.74) | KDM4EMAPTMEN1LMNAMPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118899403-A | Modification structure for lithium metal negative electrode, preparation method and application of lithium metal negative electrode | 安徽盟维新能源科技有限公司 | 2024-11-05 | — | — | CN | claimed |
| US-20220047711-A1 | PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS | GENENTECH, INC. (US) | 2022-02-17 | — | — | US | claimed |
| EP-3894427-A1 | PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS | Genentech, Inc. (US) | 2021-10-20 | — | — | EP | claimed |
| CN-113227119-A | Photocrosslinked peptides for site-specific conjugation to Fc-containing proteins | 基因泰克公司 | 2021-08-06 | — | — | CN | claimed |
| WO-2020123275-A1 | PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS | GENENTECH, INC. (US) | 2020-06-18 | — | — | WO | claimed |
| EP-3401683-A1 | DIAGNOSING METABOLIC DISEASE BY THE USE OF A BIOMARKER | Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) | 2018-11-14 | — | — | EP | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| EP-2066700-B1 | DEXTRAN FUNCTIONALIZED WITH HYDROPHOBIC AMINO ACIDS | ADOCIA (FR) | 2015-11-11 | — | — | EP | claimed |
| US-8993762-B2 | Total synthesis of thaxtomin A analogues and their intermediates | MARRONE BIO INNOVATIONS, INC. (US) | 2015-03-31 | — | — | US | claimed |
| EP-0203031-B1 | BIOLOGICALLY ACTIVE LYSINE CONTAINING OCTAPEPTIDES | The Administrators of The Tulane University Educational Fund (US) | 1992-07-29 | — | — | EP | claimed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| EP-0193113-B1 | PROCESS FOR OPTICALLY ISOMERIZING OPTICALLY ACTIVE ALPHA-AMINO ACID AMIDES AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALPHA-AMINO ACIDS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1992-01-22 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| US-4918196-A | HEATING IN PRESENCE OF STRONG BASE, SOLVENT OR SOLVENT-FREE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1990-04-17 | — | — | US | claimed |
| US-4725577-A | Biologically active lysine containing octapeptides | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1988-02-16 | — | — | US | claimed |
| US-4650787-A | SOMATOSTATIN ANALOG | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND OF NEW ORLEANS, LOUISIANA, THE, | 1987-03-17 | — | — | US | claimed |
| EP-0203031-A2 | Biologically active lysine containing octapeptides | The Administrators of The Tulane University Educational Fund (US) | 1986-11-26 | — | — | EP | claimed |
| EP-0193113-A1 | Process for optically isomerizing optically active alpha-amino acid amides and process for producing optically active alpha-amino acids | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1986-09-03 | — | — | EP | claimed |
| US-4497957-A | HYDROLYSIS OF DL-TRYPTOPHANE AMIDES BY AMIDASE PRODUCING MICROORGANISMS | UBE INDUSTRIES, LTD. (JP) | 1985-02-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220047711-A1 | PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS | FCGR2A, FCGR3B, DNPEP | KDM4E 4325/4885MAPT 3486/4885MEN1 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.